Kyntra Bio KYNB
NASDAQ KYNB
$5.25 -0.10 (-1.94%)
As of: Oct 21, 2026 · 10:01 AM EDT

Kyntra Bio (KYNB) Divestments (2025)

Updated

Kyntra Bio (KYNB) posted Divestments of $6.41 million for Q4 2025.

Analysis

Kyntra Bio (KYNB) Divestments (2025) Analysis & Trends

For FY2025, Kyntra Bio's Divestments came in at $96.62 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,131.80 Bn 1,100.39 Bn 19.71 Bn -
2 Johnson & Johnson 614.01 Bn 532.53 Bn 17.26 Bn -
3 AbbVie 503.59 Bn 476.70 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 261.50 Bn 235.19 Bn 12.86 Bn -
7 Amgen 236.24 Bn 191.64 Bn 7.24 Bn -
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn -
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn -
10 Kyntra Bio 21.25 Mn -386.69 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.41 Mn
API Access

Kyntra Bio Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=KYNB&period=max&api_key=YOUR_API_KEY